Genetic Alliance

What Genetic Alliance does

Genetic Alliance is a 501(c)(3) nonprofit health advocacy organization founded in 1986 and headquartered in Damascus, Maryland, that operates a portfolio of programs and research infrastructure serving patients with genetic conditions, disease advocacy organizations, and researchers worldwide. Its flagship program, iHope Genetic Health, runs the world's largest equitable rare-disease genomic testing network, delivering no-cost clinical whole-genome and exome sequencing to children with suspected genetic conditions in low- and middle-income countries across 25 clinical sites in 14 countries, with 3,000+ children supported and a 45%+ diagnostic yield. The organization complements iHope with a participant-centered registry platform (GA Registry, powered by Aretetic's DigitalCabinet), cooperative BioBank services, an Institutional Review Board (founding member of SMART IRB), the Disease InfoSearch directory covering 13,000+ conditions, and Registry Bootcamp training for advocacy organizations. Underlying technology integrates Illumina short-read sequencing, PacBio long-read HiFi sequencing, and 3billion's AI-powered variant interpretation platform, layered on top of HIPAA/GDPR-compliant data infrastructure.

The business model is a hybrid nonprofit structure with diversified funding streams rather than product sales. Revenue is generated through (i) major corporate sponsorships and grants — notably the $120 million Illumina global initiative launched in 2021, a 2025 Helmsley Charitable Trust grant, and NIH funding through SMART IRB and PCORnet/CENA — (ii) fee-for-service revenue from BioBank memberships ($1,000 setup plus $750/quarter), IRB review fees, and registry platform subscriptions, (iii) individual donations channeled through Zeffy, and (iv) events and educational programming. The organization is governed by an external Council and led by CEO Sharon Terry alongside a small executive team including CSO Ryan Taft (ex-Illumina VP of Scientific Research), Chief Strategy Officer Natasha Bonhomme, CFO Ruth Child, and Director of Global Genomics Jennifer Troyer (ex-NHGRI).

Genetic Alliance occupies a distinctive convening role in the genomics ecosystem as a co-founder of the National Academy of Medicine Genomics Roundtable, the Global Alliance for Genomics and Health (GA4GH), the International Rare Disease Research Consortium (IRDiRC), and SMART IRB. This standards-setting and advocacy position, combined with nearly four decades of operating history, provides the organization with brand authority, partnership access, and a participant-owned data philosophy that are difficult for newer entrants to replicate. The 2022 merger with ClinWiki and the 2026 additions of PacBio and 3billion as iHope partners underscore continued programmatic and geographic scaling, while recognition such as the Candid Platinum seal (2023) and prior FDA, Research!America, and National Academies honors reflect established credibility across policy, clinical, and patient communities.

Name

Genetic Alliance

Legal name

Genetic Alliance, Inc.

Website

https://geneticalliance.org

Company type

Private

Founded year

1986

Operating status

Operating

Headcount range

11–50 employees

Short description

Genetic Alliance is a 501(c)(3) nonprofit that operates the iHope genomic testing network and a portfolio of registry, biobank, IRB, and advocacy programs serving rare disease patients, advocacy organizations, and researchers across 14+ countries.

Ownership category

akta.pro rank

Product category

Health Advocacy and Genomic Research Services

NAICS

Voluntary Health Organizations (813212), Human Rights Organizations (813311), Business, Professional, Labor, Political, and Similar Organizations (8139)

SIC

Services-Membership Organizations (8600), Services-Health Services (8000)

akta.pro primary industry

Rare Disease & Special Needs Support Organizations (BPAGACAM)

akta.pro secondary industries

Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD), Population Genomics & Preventive Precision Health Programs (HLAAANAL)

Keywords

• Genomic testing services
• Rare disease advocacy
• Biorepository services
• Patient registry platforms
• Research infrastructure services

Headquarters

HQ city

Washington

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Government Grants and Contracts: Funding from government sources including NIH grants and contracts. Genetic Alliance participates in NIH initiatives such as SMART IRB (funded by NIH Clinical and Translational Science Awards Program) and collaborates on government-funded research initiatives.
2. Service Fees: Fee-for-service partnerships and fees generated by services including BioBank services (one-time setup fees, quarterly fees), IRB review services, and registry services. BioBank charges $1,000 setup fee, $500 IRB review fee, and $750/quarter membership fee.
3. Corporate and Industry Support: Strategic fee-for-service partnerships with industry and corporate supporters. Illumina launched a $120 million global initiative with Genetic Alliance to increase equity and improve outcomes for families impacted by genetic disease.
4. Individual Donations: Donations from individuals through platforms like Zeffy. The organization actively campaigns for donations including 'Free the Data' campaign.
5. Events: Revenue generated from events and webinars including annual conferences and educational programming.
6. iHope Program (Pro Bono): The iHope program provides clinical genomic sequencing at no cost to patients, funded through sponsors, labs, and clinical partners rather than patient revenue.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

Genetic Alliance is a 501(c)(3) nonprofit health advocacy organization that delivers clinical genomic testing through its iHope program for children with suspected rare genetic conditions, participant-centered research registries, biorepository services, and IRB review services. The organization operates disease information directories and convenes patient communities, advocacy groups, clinicians, researchers, and policy makers to advance equitable genomic medicine globally.

Product overview

Genetic Alliance is a nonprofit organization providing a platform of research infrastructure services and programs. The core offerings include: iHope Genetic Health (global genomic testing program for undiagnosed rare disease patients in underserved regions), GA Registry (participant-centered research registry powered by DigitalCabinet platform), Genetic Alliance BioBank (biorepository services for biospecimens), Genetic Alliance IRB (ethics review services for human subjects research), Disease InfoSearch (disease information directory with 13,000+ conditions), and Registry Bootcamp (training for registry development). Supporting resources include WikiAdvocacy, Expecting Health initiative, and educational publications and webinars. The organization also publishes the peer-reviewed journal Genetic Testing and Molecular Biomarkers.

Differentiator

Problem solved

Functional benefit

Brands

• iHope Genetic Health: Global program providing clinical genomic sequencing and follow-up support to children with suspected genetic conditions in low to middle income countries.
• Expecting Health
• BioBank
• Disease InfoSearch
• Registry Bootcamp
• WikiAdvocacy

Products and services

• iHope Genetic Health A global program providing clinical whole-genome and exome sequencing and follow-up support to children with suspected genetic conditions in low to middle income countries, delivered through a distributed network of 25 clinical sites across 14 countries in Africa, Asia, Latin America, and Europe.
• GA Registry (DigitalCabinet) A modern, secure, participant-centered research infrastructure platform powered by Aretetic's DigitalCabinet that enables advocacy communities to build branded registries, collect rich data, and drive research with full participant data ownership, GDPR/HIPAA compliance, and multilingual support.
• Genetic Alliance BioBank Biorepository services providing infrastructure to collect, archive, and distribute biospecimens (blood, buccal swab, saliva, urine) for nonprofit communities and organizations at cooperative rates, including sample collection kits, storage, and LIM system management.
• Genetic Alliance IRB Institutional Review Board offering human subjects research protocol review with lower costs, 15x faster turnaround times than universities, and user-friendly templates for IRB approval; founding member of SMART IRB for multisite research.
• Disease InfoSearch A consumer-facing directory of more than 13,000 diseases aggregating links to quality disease information, support groups, resources, clinical trials, and research opportunities for patients, families, researchers, and advocacy organizations.

Quantifiable outcome

• 45%+ diagnostic yield across iHope network (some clinics exceeding 60%)
• +4 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Twelve partnerships are on record, tiered core and minor.

• 3billioncoreTechnology or Integration · 5 March 20263billion became the first Asian partner of Genetic Alliance's iHope program, providing AI-powered genetic diagnostic services. Company operates across 75+ countries and utilizes AI-powered variant interpretation technology. Partnership aims to provide precision diagnostics for pediatric rare disease patients in developing nations and help reduce prolonged diagnostic odysseys.
• Pacific Biosciences (PacBio)coreTechnology or Integration · 26 February 2026PacBio joined iHope as the first long-read genomic sequencing partner, integrating HiFi long-read whole-genome sequencing into iHope's international network. Partnership increases annual patient capacity by 500-1,000 additional patients across 25 clinical sites in 14 countries. Technology can detect complex variants and structural changes that short-read sequencing typically misses. Integration expected to begin early 2026.
• ClinWikiminorStrategic or Co-development Partner · 25 January 2022Genetic Alliance and ClinWiki announced merger in January 2022, combining organizations to strengthen research and advocacy capabilities.
• IlluminacoreTechnology or Integration · 16 November 2021Illumina and Genetic Alliance launched a $120 million global initiative to increase equity and improve outcomes for families impacted by genetic disease. Illumina is the founding partner of the iHope program, providing sequencing technology and support. Partnership established the world's largest equitable rare-disease genomic testing network.
• Aretetic (DigitalCabinet)coreTechnology or IntegrationPartnership with Aretetic provides the DigitalCabinet platform for the Genetic Alliance Registry. Platform is now fully managed in-house through partnership with Aretetic. Includes tools for engagement, flexible data collection, real-time insights, GDPR and HIPAA compliance, and participant data ownership.
• NAM Genomics RoundtablecoreStrategic or Co-development PartnerGenetic Alliance is co-founder of the NAM (National Academy of Medicine) Genomics Roundtable, which convenes stakeholders to advance genomics in health care.
• Global Alliance for Genomics and Health (GA4GH)coreStrategic or Co-development PartnerGenetic Alliance is co-founder of GA4GH, a policy-framing and technical standards-setting organization for genomic data sharing globally.
• International Rare Disease Research Consortium (IRDiRC)coreStrategic or Co-development PartnerGenetic Alliance is co-founder of IRDiRC, which aims to accelerate research on rare diseases through international collaboration.
• NAM Regenerative Medicine ForumcoreStrategic or Co-development PartnerGenetic Alliance is co-founder of the NAM Regenerative Medicine Forum, supporting advancement of regenerative medicine research and policy.
• SMART IRBcoreStrategic or Co-development PartnerGenetic Alliance is a founding member of SMART IRB, a platform providing resources for multisite research and helping institutions adopt the NIH Single IRB review policy. SMART IRB is funded by NIH Clinical and Translational Science Awards Program and is free to use.
• PCORnetcoreStrategic or Co-development PartnerGenetic Alliance is a PCORnet partner through the Community Engaged Network for All (CENA). PEER platform undergirds CENA which has been a PCORnet member since 2013. Sharon Terry serves as Co-PI of PCORnet Coordinating Center and Chair of PCORnet Engagement Committee.
• Rare Disease Consortium (UK)minorStrategic or Co-development PartnerGenetic Alliance UK (through its report on rare genetic conditions) partners with the Rare Disease Consortium comprising patients, academics, industry and healthcare partners to develop regulatory frameworks for rare disease therapies.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• National Organization for Rare Disorders (NORD): Leading US rare disease advocacy nonprofit operating patient registries, research programs, and policy advocacy. Directly comparable mission and service portfolio to Genetic Alliance's advocacy and research infrastructure.
• Global Genes: US-based rare disease advocacy nonprofit focused on patient empowerment, education, and research connections. Closely aligned with Genetic Alliance's mission to advance rare disease genetics and patient outcomes.
• EURORDIS - Rare Diseases Europe: European umbrella organization for rare disease patient organizations, comparable to Genetic Alliance in mission, advocacy, and community-building role across geographies.
• EveryLife Foundation for Rare Diseases: Public policy advocacy organization for rare diseases with comparable federal advocacy and patient community engagement focus.

Emerging players

• 3billion: AI-powered rare disease diagnostic company now partnering with Genetic Alliance's iHope. Provides variant interpretation services across 75+ countries; comparable AI/genomics technology stack.

Broad incumbents

• National Human Genome Research Institute (NHGRI): Federal agency driving genomics research, including the Undiagnosed Diseases Network and All of Us. Provides genomic testing at scale with broader scope and government funding compared to Genetic Alliance.
• Invitae: Commercial genetic testing company offering clinical genomic sequencing including rare disease panels. While for-profit, provides the commercial-scale alternative to iHope's pro bono model.
• Genomics England: Government-backed initiative delivering whole-genome sequencing at national scale (100,000 Genomes Project). Operates a comparable rare disease genomic testing model with much larger scale and funding.

Others

• Pacific Biosciences (PacBio): Long-read sequencing technology provider and iHope partner. Comparable genomics focus but operates as a sequencing platform vendor rather than advocacy organization.
• Illumina Inc. Founding partner of iHope with a $120M initiative; sequencing technology giant enabling rare disease genomics. Enabler/funder relationship rather than direct competitor.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/geneticalliance
• YouTubeyoutube.com/user/geneticalliance
• Facebookfacebook.com/geneticalliance
• LinkedInlinkedin.com/company/genetic-alliance

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genetic Alliance